SciSparc (SPRC) EBITDA (2016 - 2022)
SciSparc's (SPRC) quarterly EBITDA came in at $1.6 million in Q4 2022, up 730.46% quarter-over-quarter from $197000.0 in Q2 2019.
Analysis
SciSparc (SPRC) EBITDA (2016 - 2022) Analysis & Trends
SciSparc has disclosed EBITDA across 5 years of filings, most recently posting $1.6 million for Q4 2022.
- In Q4 2022, EBITDA changed N/A year-over-year to $1.6 million; the TTM figure through Dec 2022 stood at $5.4 million (changed N/A YoY), while the FY2025 annual figure was -$8.4 million, down 14.46% from the prior year.
- EBITDA came in at $1.6 million for Q4 2022 at SciSparc, up from $197000.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of $2.1 million in Q1 2018 to a low of $197000.0 in Q2 2019.
- Average EBITDA over 3 years is $1.6 million, with a median of $1.7 million recorded in 2018.
- Year-over-year, EBITDA surged 230.85% in 2018 and plunged 88.06% in 2019.
- Over 3 years, EBITDA stood at $1.7 million in 2018, then sank by 88.61% to $197000.0 in 2019, then soared by 730.46% to $1.6 million in 2022.
- Per Business Quant data, the three most recent EBITDA figures were $1.6 million in Q4 2022, $197000.0 in Q2 2019, and $1.9 million in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 4.27 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 1.22 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -505.13 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 697.90 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 330.80 Mn |
| 10 | SciSparc | 614,715.73 | 614,715.73 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 1.64 Mn |
| Jun 30, 2019 | 197,000.00 |
| Mar 31, 2019 | 1.85 Mn |
| Dec 31, 2018 | 1.73 Mn |
| Sep 30, 2018 | 1.73 Mn |
| Jun 30, 2018 | 1.65 Mn |
| Mar 31, 2018 | 2.13 Mn |
| Dec 31, 2017 | 2.57 Mn |
| Sep 30, 2017 | 1.11 Mn |
| Jun 30, 2017 | 1.43 Mn |
| Mar 31, 2017 | 645,000.00 |
| Dec 31, 2016 | 437,000.00 |
| Sep 30, 2016 | 526,000.00 |
| Jun 30, 2016 | 552,000.00 |